Show simple item record

dc.contributor.authorBonomi, P. D.
dc.contributor.authorGandara, D.
dc.contributor.authorHirsch, F. R.
dc.contributor.authorKerr, K. M.
dc.contributor.authorObasaju, C.
dc.contributor.authorPaz-Ares, L.
dc.contributor.authorBellomo, C.
dc.contributor.authorBradley, J. D.
dc.contributor.authorBunn, P. A.
dc.contributor.authorCulligan, M.
dc.contributor.authorJett, J. R.
dc.contributor.authorKim, E. S.
dc.contributor.authorLanger, C. J.
dc.contributor.authorNatale, R. B.
dc.contributor.authorNovello, S.
dc.contributor.authorPérol, M.
dc.contributor.authorRamalingam, S. S.
dc.contributor.authorReck, M.
dc.contributor.authorReynolds, C. H.
dc.contributor.authorSmit, E. F.
dc.contributor.authorSocinski, M. A.
dc.contributor.authorSpigel, D. R.
dc.contributor.authorVansteenkiste, J. F.
dc.contributor.authorWakelee, H.
dc.contributor.authorThatcher, N.
dc.date.accessioned2018-11-19T14:30:06Z
dc.date.available2018-11-19T14:30:06Z
dc.date.issued2018-08-01
dc.identifier.citationBonomi , P D , Gandara , D , Hirsch , F R , Kerr , K M , Obasaju , C , Paz-Ares , L , Bellomo , C , Bradley , J D , Bunn , P A , Culligan , M , Jett , J R , Kim , E S , Langer , C J , Natale , R B , Novello , S , Pérol , M , Ramalingam , S S , Reck , M , Reynolds , C H , Smit , E F , Socinski , M A , Spigel , D R , Vansteenkiste , J F , Wakelee , H & Thatcher , N 2018 , ' Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer ' , Annals of Oncology , vol. 29 , no. 8 , pp. 1701-1709 . https://doi.org/10.1093/annonc/mdy196en
dc.identifier.issn0923-7534
dc.identifier.otherPURE: 140625536
dc.identifier.otherPURE UUID: 557a37c4-2586-46cc-9ab3-fdd40fe76eb3
dc.identifier.otherScopus: 85055507014
dc.identifier.urihttp://hdl.handle.net/2164/11465
dc.identifier.urihttp://www.scopus.com/inward/record.url?scp=85055507014&partnerID=8YFLogxKen
dc.descriptionWriting assistance was funded by Eli Lilly and Company (no grant numbers apply).en
dc.format.extent9
dc.language.isoeng
dc.relation.ispartofAnnals of Oncologyen
dc.rightsC The Author(s) 2018. Published by Oxford University Press on behalf of the European Society for Medical Oncology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.comen
dc.subjectEGFR-directed monoclonal antibodiesen
dc.subjectNon-small-cell lung canceren
dc.subjectSquamous cell lung canceren
dc.subjectR Medicineen
dc.subjectHematologyen
dc.subjectOncologyen
dc.subject.lccRen
dc.titlePredictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung canceren
dc.typeJournal itemen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1093/annonc/mdy196
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85055507014&partnerID=8YFLogxKen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record